Analysts expect over 2020 rising revenue Astrazeneca, huge dividend

Tomorrow the English company Astrazeneca will publish its past quarters results. Over the current book year the total revenue from the company in Cambridge will be 26,59 billion GBp (consensus estimates). This is slightly more than 2019's revenue of 24,38 billion GBp.

Historical revenues and results Astrazeneca plus estimates 2020

aandelenanalyse Astrazeneca

The analysts expect for 2020 a net profit of 5,35 billion GBp. The majority of the analysts expects for this year a profit per share of 394 GBp. Based on this the price/earnings-ratio is 20,21.

Huge dividend Astrazeneca

Per share the analysts are expecting a dividend of 279 GBp per share. Thus the dividend yield equals 3,5 percent. The average dividend yield of the pharmaceutical companies equals a low 0,21 percent.

Based on the current number of shares Astrazeneca 's market capitalization equals 10089,44 billion GBp. The Astrazeneca stock was the past 12 months quite volatile. Since last November the stock is 11 percent higher. This year the stock price moved between 5871 and 10120 GBp.

At 9.45 the stock trades 3,18 percent higher at 7963 GBp.

Historical stock prices Astrazeneca

fundamental research astrazeneca News Wire & Equity Research: +31 084-0032-842

Copyright B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.